期刊
JOURNAL OF NEUROSCIENCE
卷 27, 期 26, 页码 7006-7010出版社
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.1919-07.2007
关键词
transthyretin; presenilin 1; transgenic mice; A beta peptide; Alzheimer's disease; amyloid
资金
- NIA NIH HHS [R01 AG027854, AG027854, AG021494, R01 AG021494] Funding Source: Medline
A cardinal pathological lesion of Alzheimer's disease (AD) is the deposition of amyloid beta(A beta) in the brain. We previously reported that exposing transgenic mice harboring APPswe/PS1 Delta E9 transgenes to an enriched environment resulted in reduced levels of A beta peptides and deposition, findings that were correlated with an increase in the expression of TTR, encoding transthyretin (TTR). TTR is expressed at high levels in the choroid plexus and known to bind A beta peptides and modulate their aggregation in vitro and in vivo. To explore the impact of TTR expression on A beta levels and deposition in vivo, we crossed ceAPPswe/PS1 Delta E9 transgenic mice to mice with genetic ablations of TTR. We now report that the levels of detergent-soluble and formic acid-soluble levels of A beta and deposition are elevated in the brains of ceAPPswe/PS1 Delta E9/TTR+/- mice compared with age-matched ceAPPswe/PS1 Delta E9/TTR+/ + mice. Moreover, A beta deposition is significantly accelerated in the hippocampus and cortex of ceAPPswe/PS1 Delta E9/TTR+/- mice. Our results strongly suggest that TTR plays a critical role in modulating A beta deposition in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据